메뉴 건너뛰기




Volumn 43, Issue 3, 2010, Pages 323-331

Chagas disease: Present status of pathogenic mechanisms and chemotherapy

Author keywords

Chagas disease; Chemotherapy; Nifurtimox; Prostaglandins; Trypanosoma cruzi

Indexed keywords

MASTIGOPHORA (FLAGELLATES); MUS; PROTOZOA; TRYPANOSOMA CRUZI;

EID: 78650059497     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602010000300009     Document Type: Article
Times cited : (60)

References (111)
  • 1
    • 40649099340 scopus 로고    scopus 로고
    • Trypanosoma cruzi: The role of PGE2 in immune response during the acute phase of experimental infection
    • ABDALLA, G. K., FARIA, G. E., SILVA, K. T., CASTRO, E. C., REIS, M. A., and MICHELIN, M. A. (2008): Trypanosoma cruzi: the role of PGE2 in immune response during the acute phase of experimental infection. Exp Parasitol 118, 514-21.
    • (2008) Exp Parasitol , vol.118 , pp. 514-521
    • Abdalla, G.K.1    Faria, G.E.2    Silva, K.T.3    Castro, E.C.4    Reis, M.A.5    Michelin, M.A.6
  • 2
    • 28144459142 scopus 로고    scopus 로고
    • Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: The results of clinical and parasitological examinations 11 years post-treatment
    • APT, W., ARRIBADA, A., ZULANTAY, I., SOLARI, A., SANCHEZ, G., MUNDACA, K., CORONADO, X., RODRIGUEZ, J., GIL, L. C., and OSUNA, A. (2005): Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment. Ann Trop Med Parasitol 99, 733-41.
    • (2005) Ann Trop Med Parasitol , vol.99 , pp. 733-741
    • Apt, W.1    Arribada, A.2    Zulantay, I.3    Solari, A.4    Sanchez, G.5    Mundaca, K.6    Coronado, X.7    Rodriguez, J.8    Gil, L.C.9    Osuna, A.10
  • 3
    • 56949093019 scopus 로고    scopus 로고
    • Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy
    • ARAUJO-JORGE, T. C., WAGHABI, M. C., SOEIRO MDE, N., KERAMIDAS, M., BAILLY, S., and FEIGE, J. J. (2008): Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy. Cytokine Growth Factor Rev 19, 405-13.
    • (2008) Cytokine Growth Factor Rev , vol.19 , pp. 405-413
    • Araujo-Jorge, T.C.1    Waghabi, M.C.2    Soeiro, M.N.3    Keramidas, M.4    Bailly, S.5    Feige, J.J.6
  • 5
    • 0037414069 scopus 로고    scopus 로고
    • Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin
    • BELHASSEN, L., PELLE, G., DUBOISR-ANDE, J. L., and ADNOT, S. (2003): Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin. J Am Coll Cardiol 41, 1198-204.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1198-1204
    • Belhassen, L.1    Pelle, G.2    Duboisr-Ande, J.L.3    Adnot, S.4
  • 7
    • 67349188092 scopus 로고    scopus 로고
    • Prophylaxis of sudden cardiac death in chronic Chagas disease
    • BESTETTI, R. B. and CARDINALLI-NETO, A. (2009): Prophylaxis of sudden cardiac death in chronic Chagas disease. Int J Cardiol 134, 428-9.
    • (2009) Int J Cardiol , vol.134 , pp. 428-429
    • Bestetti, R.B.1    Cardinalli-Neto, A.2
  • 8
    • 68949203206 scopus 로고    scopus 로고
    • Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: Value and limitations
    • BRITTO, C. C. (2009): Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. Mem Inst Oswaldo Cruz 104 Suppl 1, 122-35.
    • (2009) Mem Inst Oswaldo Cruz , vol.104 , Issue.SUPPL. 1 , pp. 122-135
    • Britto, C.C.1
  • 9
    • 43249116465 scopus 로고    scopus 로고
    • Drug induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease
    • BUSTAMANTE, J. M., BIXBY, L. M., and TARLETON, R. L. (2008): Drug induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat Med 14, 542-50.
    • (2008) Nat Med , vol.14 , pp. 542-550
    • Bustamante, J.M.1    Bixby, L.M.2    Tarleton, R.L.3
  • 10
    • 44349169957 scopus 로고    scopus 로고
    • Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions
    • CALDAS, I. S., TALVANI, A., CALDAS, S., CARNEIRO, C. M., DE LANA, M., DA MATTA GUEDES, P. M. and BAHIA, M. T. (2008): Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. Parasitol Res 103, 413-21.
    • (2008) Parasitol Res , vol.103 , pp. 413-421
    • Caldas, I.S.1    Talvani, A.2    Caldas, S.3    Carneiro, C.M.4    de Lana, M.5    da Matta, G.P.M.6    Bahia, M.T.7
  • 11
    • 9644254077 scopus 로고    scopus 로고
    • Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections
    • CARDONI, R. L. and ANTÚNEZ, M. I. (2004): Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections. Mediators Inflamm 13, 235-40.
    • (2004) Mediators Inflamm , vol.13 , pp. 235-240
    • Cardoni, R.L.1    Antúnez, M.I.2
  • 12
    • 33748669644 scopus 로고    scopus 로고
    • Toxic side effects of drugs used to treat Chagas disease (American trypanosomiasis)
    • CASTRO, J. A., DE MECCA, M. M. and BARTEL, L. C. (2006): Toxic side effects of drugs used to treat Chagas disease (American trypanosomiasis). Hum Exp Toxicol 25, 471-9.
    • (2006) Hum Exp Toxicol , vol.25 , pp. 471-479
    • Castro, J.A.1    de Mecca, M.M.2    Bartel, L.C.3
  • 13
    • 0030641290 scopus 로고    scopus 로고
    • Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes
    • CAUGHEY, G. E., POULIOT, M., CLELAND, L. G. and JAMES, M. J. (1997): Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes. J Immunol 158, 351-8.
    • (1997) J Immunol , vol.158 , pp. 351-358
    • Caughey, G.E.1    Pouliot, M.2    Cleland, L.G.3    James, M.J.4
  • 16
    • 70149111718 scopus 로고    scopus 로고
    • Present situation and new strategies for Chagas disease chemotherapy: A proposal
    • COURA, J. R. (2009): Present situation and new strategies for Chagas disease chemotherapy: a proposal. Mem Inst Oswaldo Cruz 104, 549-54.
    • (2009) Mem Inst Oswaldo Cruz , vol.104 , pp. 549-554
    • Coura, J.R.1
  • 17
    • 68949217392 scopus 로고    scopus 로고
    • Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery
    • COURA, J. R. and DIAS, J. C. (2009): Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery. Mem Inst Oswaldo Cruz 104 Suppl 1, 31-40.
    • (2009) Mem Inst Oswaldo Cruz , vol.104 , Issue.SUPPL. 1 , pp. 31-40
    • Coura, J.R.1    Dias, J.C.2
  • 18
    • 61449148441 scopus 로고    scopus 로고
    • Trypanosoma cruzi triggers an early type I IFN response in vivo at the site of intradermal infection
    • CHESSLER, A. D., UNNIKRISHNAN, M., BEI, A. K., DAILY, J. P. and BURLEIGH, B. A. (2009): Trypanosoma cruzi triggers an early type I IFN response in vivo at the site of intradermal infection. J Immunol 182, 2288-96.
    • (2009) J Immunol , vol.182 , pp. 2288-2296
    • Chessler, A.D.1    Unnikrishnan, M.2    Bei, A.K.3    Daily, J.P.4    Burleigh, B.A.5
  • 19
    • 34248196591 scopus 로고    scopus 로고
    • Immune regulation by microvascular endothelial cells: Directing innate and adaptive immunity, coagulation, and inflammation
    • DANESE, S., DEJANA, E. and FIOCCHI, C. (2007): Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 178, 6017-22.
    • (2007) J Immunol , vol.178 , pp. 6017-6022
    • Danese, S.1    Dejana, E.2    Fiocchi, C.3
  • 21
    • 0036162789 scopus 로고    scopus 로고
    • Pathogenesis of chronic chagas heart disease: Parasite persistence and autoimmune responses versus cardiac remodelling and neurohormonal activation
    • DAVILA, D. F., ROSSELL, O. and DE BELLABARBA, G. A. (2002): Pathogenesis of chronic chagas heart disease: parasite persistence and autoimmune responses versus cardiac remodelling and neurohormonal activation. Int J Parasitol 32, 107-9.
    • (2002) Int J Parasitol , vol.32 , pp. 107-109
    • Davila, D.F.1    Rossell, O.2    de Bellabarba, G.A.3
  • 26
    • 68949209377 scopus 로고    scopus 로고
    • The importance of apoptosis for immune regulation in Chagas disease
    • DOSREIS, G. A. and LOPES, M. F. (2009a): The importance of apoptosis for immune regulation in Chagas disease. Mem Inst Oswaldo Cruz 104, 259-62.
    • (2009) Mem Inst Oswaldo Cruz , vol.104 , pp. 259-262
    • Dosreis, G.A.1    Lopes, M.F.2
  • 27
    • 68949209377 scopus 로고    scopus 로고
    • The importance of apoptosis for immune regulation in Chagas disease
    • DOSREIS, G. A. and LOPES, M. F. (2009b): The importance of apoptosis for immune regulation in Chagas disease. Mem Inst Oswaldo Cruz 104 Suppl 1, 259-62.
    • (2009) Mem Inst Oswaldo Cruz , vol.104 , Issue.SUPPL. 1 , pp. 259-262
    • Dosreis, G.A.1    Lopes, M.F.2
  • 28
    • 59849123911 scopus 로고    scopus 로고
    • Chagas disease: State-of-the-art of diagnosis and management
    • DUBNER, S., SCHAPACHNIK, E., RIERA, A. R. and VALERO, E. (2008): Chagas disease: state-of-the-art of diagnosis and management. Cardiol J 15, 493-504.
    • (2008) Cardiol J , vol.15 , pp. 493-504
    • Dubner, S.1    Schapachnik, E.2    Riera, A.R.3    Valero, E.4
  • 31
    • 84884527707 scopus 로고    scopus 로고
    • Eicosanoids and the vascular endothelium
    • EGAN, K. and FITZGERALD, G. A. (2006): Eicosanoids and the vascular endothelium. Handb Exp Pharmacol, 189-211.
    • (2006) Handb Exp Pharmacol , pp. 189-211
    • Egan, K.1    Fitzgerald, G.A.2
  • 32
    • 0021857484 scopus 로고
    • Abnormalities of the coronary microcirculation in acute murine Chagas disease
    • FACTOR, S. M., CHO, S., WITTNER, M. and TANOWITZ, H. (1985): Abnormalities of the coronary microcirculation in acute murine Chagas disease. Am J Trop Med Hyg 34, 246-53.
    • (1985) Am J Trop Med Hyg , vol.34 , pp. 246-253
    • Factor, S.M.1    Cho, S.2    Wittner, M.3    Tanowitz, H.4
  • 33
    • 42949119652 scopus 로고    scopus 로고
    • Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas disease and enhances the efficacy of nifurtimox
    • FAÚNDEZ, M., LÓPEZ-MUNOZ, R., TORRES, G., MORELLO, A., FERREIRA, J., KEMMERLING, U., ORELLANA, M. and MAYA, J. D. (2008): Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas disease and enhances the efficacy of nifurtimox. Antimicrob Agents Chemother 52, 1837-9.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 1837-1839
    • Faúndez, M.1    López-Munoz, R.2    Torres, G.3    Morello, A.4    Ferreira, J.5    Kemmerling, U.6    Orellana, M.7    Maya, J.D.8
  • 35
    • 0023609713 scopus 로고
    • Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease
    • FILARDI, L. S. and BRENER, Z. (1987): Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 81, 755-9.
    • (1987) Trans R Soc Trop Med Hyg , vol.81 , pp. 755-759
    • Filardi, L.S.1    Brener, Z.2
  • 38
    • 33846025798 scopus 로고    scopus 로고
    • Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages
    • FREIRE-DE-LIMA, C. G., XIAO, Y. Q., GARDAI, S. J., BRATTON, D. L., SCHIEMANN, W. P. and HENSON, P. M. (2006): Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem 281, 38376-84.
    • (2006) J Biol Chem , vol.281 , pp. 38376-38384
    • Freire-De-Lima, C.G.1    Xiao, Y.Q.2    Gardai, S.J.3    Bratton, D.L.4    Schiemann, W.P.5    Henson, P.M.6
  • 39
    • 64849114195 scopus 로고    scopus 로고
    • Chagasic antibodies induce cardiac COX-2/iNOS mRNA expression with PGE2/NO production
    • GANZINELLI, S., BORDA, E., JOENSEN, L. and STERIN-BORDA, L. (2009): Chagasic antibodies induce cardiac COX-2/iNOS mRNA expression with PGE2/NO production. Int J Cardiol 134, 212-23.
    • (2009) Int J Cardiol , vol.134 , pp. 212-223
    • Ganzinelli, S.1    Borda, E.2    Joensen, L.3    Sterin-Borda, L.4
  • 41
    • 0028300269 scopus 로고
    • Identification of antibodies with muscarinic cholinergic activity in human Chagas disease: Pathological implications
    • GOIN, J. C., BORDA, E., LEIROS, C. P., STORINO, R. and STERINBORDA, L. (1994): Identification of antibodies with muscarinic cholinergic activity in human Chagas disease: pathological implications. J Auton Nerv Syst 47, 45-52.
    • (1994) J Auton Nerv Syst , vol.47 , pp. 45-52
    • Goin, J.C.1    Borda, E.2    Leiros, C.P.3    Storino, R.4    Sterinborda, L.5
  • 46
    • 28844480597 scopus 로고    scopus 로고
    • Prothrombotic state in early stages of chronic Chagas disease. Its association with thrombotic risk factors
    • S3-38-S3-48
    • HERRERA, R. N., DÍAZ, E., PÉREZ AGUILAR, R., BIANCHI, J., BERMAN, S. and LUCIARDI, H. L. (2005): [Prothrombotic state in early stages of chronic Chagas disease. Its association with thrombotic risk factors]. Arch Cardiol Mex 75 Suppl 3, S3-38-48.
    • (2005) Arch Cardiol Mex , vol.75 , Issue.SUPPL. 3
    • Herrera, R.N.1    Díaz, E.2    Pérez Aguilar, R.3    Bianchi, J.4    Berman, S.5    Luciardi, H.L.6
  • 49
    • 59649121544 scopus 로고    scopus 로고
    • Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas cardiomyopathy
    • HISS, F. C., LASCALA, T. F., MACIEL, B. C., MARÍN-NETO, J. A. and SIMOES, M. V. (2009): Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas cardiomyopathy. JACC Cardiovasc Imaging 2, 164-72.
    • (2009) JACC Cardiovasc Imaging , vol.2 , pp. 164-172
    • Hiss, F.C.1    Lascala, T.F.2    Maciel, B.C.3    Marín-Neto, J.A.4    Simoes, M.V.5
  • 50
    • 33750630391 scopus 로고    scopus 로고
    • Non-steroidal anti-inflammatory drugs selectively inhibit cytokine production by NK cells and gamma delta T cells
    • INAOKA, M., KIMISHIMA, M., TAKAHASHI, R. and SHIOHARA, T. (2006): Non-steroidal anti-inflammatory drugs selectively inhibit cytokine production by NK cells and gamma delta T cells. Exp Dermatol 15, 981-90.
    • (2006) Exp Dermatol , vol.15 , pp. 981-990
    • Inaoka, M.1    Kimishima, M.2    Takahashi, R.3    Shiohara, T.4
  • 52
    • 34547914831 scopus 로고    scopus 로고
    • IL-3 is an important differentiation factor for the development of prostaglandin E2-producing macrophages between C57BL/6 and BALB/c mice
    • KURODA, E., NOGUCHI, J., DOI, T., UEMATSU, S., AKIRA, S. and YAMASHITA, U. (2007): IL-3 is an important differentiation factor for the development of prostaglandin E2-producing macrophages between C57BL/6 and BALB/c mice. Eur J Immunol 37, 2185-95.
    • (2007) Eur J Immunol , vol.37 , pp. 2185-2195
    • Kuroda, E.1    Noguchi, J.2    Doi, T.3    Uematsu, S.4    Akira, S.5    Yamashita, U.6
  • 53
    • 0020852961 scopus 로고
    • Chronic Chagas cardiomyopathy: Effects of dipyradamole on ventricular dynamics
    • KUSCHNIR, E., SGAMMINI, H., CASTRO, R., EVEQUOZ, C. and LEDESMA, R. (1983): [Chronic Chagas cardiomyopathy: effects of dipyradamole on ventricular dynamics]. Arq Bras Cardiol 41, 373-8.
    • (1983) Arq Bras Cardiol , vol.41 , pp. 373-378
    • Kuschnir, E.1    Sgammini, H.2    Castro, R.3    Evequoz, C.4    Ledesma, R.5
  • 54
    • 0030512179 scopus 로고    scopus 로고
    • Soluble cell adhesion molecules in human Chagas disease: Association with disease severity and stage of infection
    • LAUCELLA, S., DE TITTO, E. H., SEGURA, E. L., ORN, A. and ROTTENBERG, M. E. (1996): Soluble cell adhesion molecules in human Chagas disease: association with disease severity and stage of infection. Am J Trop Med Hyg 55, 629-34.
    • (1996) Am J Trop Med Hyg , vol.55 , pp. 629-634
    • Laucella, S.1    de Titto, E.H.2    Segura, E.L.3    Orn, A.4    Rottenberg, M.E.5
  • 55
    • 0033867994 scopus 로고    scopus 로고
    • Experimental Chagas disease: Phagocytosis of apoptotic lymphocytes deactivates macrophages and fuels parasite growth
    • LOPES, M. F. and DOSREIS, G. A. (2000): Experimental Chagas disease: phagocytosis of apoptotic lymphocytes deactivates macrophages and fuels parasite growth. Apoptosis 5, 221-4.
    • (2000) Apoptosis , vol.5 , pp. 221-224
    • Lopes, M.F.1    Dosreis, G.A.2
  • 56
    • 0033984242 scopus 로고    scopus 로고
    • Cardiac autonomic denervation in congestive heart failure: Comparison of Chagas heart disease with other dilated cardiomyopathy
    • MACHADO, C. R., CAMARGOS, E. R., GUERRA, L. B. and MOREIRA, M. C. (2000): Cardiac autonomic denervation in congestive heart failure: comparison of Chagas heart disease with other dilated cardiomyopathy. Hum Pathol 31, 3-10.
    • (2000) Hum Pathol , vol.31 , pp. 3-10
    • Machado, C.R.1    Camargos, E.R.2    Guerra, L.B.3    Moreira, M.C.4
  • 58
    • 73249149735 scopus 로고    scopus 로고
    • Update on Chagas heart disease on the first centenary of its discovery
    • MARÍN-NETO, J. A. and RASSI, A., JR. (2009): Update on Chagas heart disease on the first centenary of its discovery. Rev Esp Cardiol 62, 1211-6.
    • (2009) Rev Esp Cardiol , vol.62 , pp. 1211-1216
    • Marín-Neto, J.A.1    Rassi, A.2
  • 59
    • 68949220484 scopus 로고    scopus 로고
    • The BENEFIT trial: Testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
    • MARÍN-NETO, J. A., RASSI, A., JR., AVEZUM, A., JR., MATTOS, A. C. and RASSI, A. (2009): The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz 104, 319-24.
    • (2009) Mem Inst Oswaldo Cruz , vol.104 , pp. 319-324
    • Marín-Neto, J.A.1    Rassi, A.2    Avezum, A.3    Mattos, A.C.4    Rassi, A.5
  • 60
    • 45549100534 scopus 로고    scopus 로고
    • Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)
    • MARÍN-NETO, J. A., RASSI, A., JR., MORILLO, C. A., AVEZUM, A., CONNOLLY, S. J., SOSAESTANI, S., ROSAS, F. and YUSUF, S. (2008): Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J 156, 37-43.
    • (2008) Am Heart J , vol.156 , pp. 37-43
    • Marín-Neto, J.A.1    Rassi, A.2    Morillo, C.A.3    Avezum, A.4    Connolly, S.J.5    Sosaestani, S.6    Rosas, F.7    Yusuf, S.8
  • 63
    • 0030911717 scopus 로고    scopus 로고
    • Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi
    • MAYA, J. D., REPETTO, Y., AGOSIN, M., OJEDA, J. M., TELLEZ, R., GAULE, C. and MORELLO, A. (1997): Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi. Mol Biochem Parasitol 86, 101-6.
    • (1997) Mol Biochem Parasitol , vol.86 , pp. 101-106
    • Maya, J.D.1    Repetto, Y.2    Agosin, M.3    Ojeda, J.M.4    Tellez, R.5    Gaule, C.6    Morello, A.7
  • 64
    • 24644524015 scopus 로고    scopus 로고
    • Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection
    • MICHELIN, M. A., SILVA, J. S. and CUNHA, F. Q. (2005): Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Exp Parasitol 111, 71-9.
    • (2005) Exp Parasitol , vol.111 , pp. 71-79
    • Michelin, M.A.1    Silva, J.S.2    Cunha, F.Q.3
  • 68
    • 65649117884 scopus 로고    scopus 로고
    • Amiodarone and itraconazole: A rational therapeutic approach for the treatment of chronic Chagas disease
    • PANIZMON-DOLFI, A. E., PEREZALVAREZ, A. M., LANZA, G., MARQUEZ, E. and CONCEPCION, J. L. (2009): Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas disease. Chemotherapy 55, 228-33.
    • (2009) Chemotherapy , vol.55 , pp. 228-233
    • Panizmon-Dolfi, A.E.1    Perezalvarez, A.M.2    Lanza, G.3    Marquez, E.4    Concepcion, J.L.5
  • 72
    • 0033541459 scopus 로고    scopus 로고
    • Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection
    • PINGEFILHO, P., TADOKORO, C. E. and ABRAHAMSOHN, I. A. (1999): Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell Immunol 193, 90-8.
    • (1999) Cell Immunol , vol.193 , pp. 90-98
    • Pingefilho, P.1    Tadokoro, C.E.2    Abrahamsohn, I.A.3
  • 74
    • 0042706732 scopus 로고    scopus 로고
    • Microcirculation and Chagas disease: Hypothesis and recent results
    • RAMOS, S. G. AND ROSSI, M. A. (1999): Microcirculation and Chagas disease: hypothesis and recent results. Rev Inst Med Trop Sao Paulo 41, 123-9.
    • (1999) Rev Inst Med Trop Sao Paulo , vol.41 , pp. 123-129
    • Ramos, S.G.1    Rossi, M.A.2
  • 75
    • 64749110340 scopus 로고    scopus 로고
    • Challenges and opportunities for primary, secondary and tertiary prevention of Chagas disease
    • RASSI, A., JR., DIAS, J. C., MARIN-NETO, J. A. and RASSI, A. (2009a): Challenges and opportunities for primary, secondary and tertiary prevention of Chagas disease. Heart 95, 524-34.
    • (2009) Heart , vol.95 , pp. 524-534
    • Rassi, A.1    Dias, J.C.2    Marin-Neto, J.A.3    Rassi, A.4
  • 76
    • 78650064782 scopus 로고    scopus 로고
    • Predicting prognosis in patients with Chagas disease: Why are the results of various studies so different?
    • RASSI, A., JR. and RASSI, A. (2009): Predicting prognosis in patients with Chagas disease: Why are the results of various studies so different? Int J Cardiol.
    • (2009) Int J Cardiol
    • Rassi, A.1    Rassi, A.2
  • 77
    • 68949212150 scopus 로고    scopus 로고
    • Chagas heart disease: Pathophysiologic mechanisms, prognostic factors and risk stratification
    • RASSI, A., JR., RASSI, A. and MARIN-NETO, J. A. (2009b): Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz 104 Suppl 1, 152-8.
    • (2009) Mem Inst Oswaldo Cruz 104 Suppl , vol.1 , pp. 152-158
    • Rassi, A.1    Rassi, A.2    Marin-Neto, J.A.3
  • 78
    • 68949212150 scopus 로고    scopus 로고
    • Chagas heart disease: Pathophysiologic mechanisms, prognostic factors and risk stratification
    • RASSI, A., JR., RASSI, A. and MARIN-NETO, J. A (2009c): Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz 104, 152-8.
    • (2009) Mem Inst Oswaldo Cruz , vol.104 , pp. 152-158
    • Rassi Jr., A.1    Rassi, A.2    Marin-Neto, J.A.3
  • 79
    • 33947593827 scopus 로고    scopus 로고
    • Predictors of mortality in chronic Chagas disease: A systematic review of observational studies
    • RASSI, A., JR., RASSI, A. and RASSI, S. G. (2007): Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 115, 1101-8.
    • (2007) Circulation , vol.115 , pp. 1101-1108
    • Rassi Jr., A.1    Rassi, A.2    Rassi, S.G.3
  • 81
    • 33644875239 scopus 로고    scopus 로고
    • Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)
    • REYES, P. A. and VALLEJO, M. (2005): Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection). Cochrane Database Syst Rev, CD004102.
    • (2005) Cochrane Database Syst Rev
    • Reyes, P.A.1    Vallejo, M.2
  • 82
    • 67449147044 scopus 로고    scopus 로고
    • Enhanced parasympathetic activity in Chagas disease still stands in need of proof
    • RIBEIRO, A. L., DE CARVALHO, A. C., LOMBARDI, F., TEIXEIRA, M. M. and ROCHA, M. O. (2009a): Enhanced parasympathetic activity in Chagas disease still stands in need of proof. Int J Cardiol 135, 406-8.
    • (2009) Int J Cardiol , vol.135 , pp. 406-408
    • Ribeiro, A.L.1    de Carvalho, A.C.2    Lombardi, F.3    Teixeira, M.M.4    Rocha, M.O.5
  • 87
    • 68949221182 scopus 로고    scopus 로고
    • Morbidity and prognostic factors in chronic chagasic cardiopathy
    • ROCHA, M. O., NUNES, M. C. and RIBEIRO, A. L. (2009): Morbidity and prognostic factors in chronic chagasic cardiopathy. Mem Inst Oswaldo Cruz 104 Suppl 1, 159-66.
    • (2009) Mem Inst Oswaldo Cruz , vol.104 , Issue.SUPPL. 1 , pp. 159-166
    • Rocha, M.O.1    Nunes, M.C.2    Ribeiro, A.L.3
  • 88
    • 33751076253 scopus 로고    scopus 로고
    • Characterization of cardiopulmonary function and cardiac muscarinic and adrenergic receptor density adaptation in C57BL/6 mice with chronic Trypanosoma cruzi infection
    • ROCHA, N. N., GARCIA, S., GIMENEZ, L. E., HERNANDEZ, C. C., SENRA, J. F., LIMA, R. S., CYRINO, F., BOUSKELA, E., SOARES, M. B., RIBEIRO DOS SANTOS, R. and CAMPOS DE CARVALHO, A. C. (2006b): Characterization of cardiopulmonary function and cardiac muscarinic and adrenergic receptor density adaptation in C57BL/6 mice with chronic Trypanosoma cruzi infection. Parasitology 133, 729-37.
    • (2006) Parasitology , vol.133 , pp. 729-737
    • Rocha, N.N.1    Garcia, S.2    Gimenez, L.E.3    Hernandez, C.C.4    Senra, J.F.5    Lima, R.S.6    Cyrino, F.7    Bouskela, E.8    Soares, M.B.9    dos Santos, R.R.10    de Campos, C.A.C.11
  • 89
    • 0030003390 scopus 로고    scopus 로고
    • Coronary microvascular abnormalities in Chagas disease
    • ROSSI, M. A. AND RAMOS, S. G. (1996): Coronary microvascular abnormalities in Chagas disease. Am Heart J 132, 207-10.
    • (1996) Am Heart J , vol.132 , pp. 207-210
    • Rossi, M.A.1    Ramos, S.G.2
  • 90
  • 91
    • 39749202944 scopus 로고    scopus 로고
    • Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern
    • SATHLERA-VELAR, R., VITELLIA-VELAR, D. M., MASSARA, R. L., DE LANA, M., PINTO DIAS, J. C., TEIXEIRA-CARVALHO, A., ELOI-SANTOS, S. M. and MARTINS-FILHO, O. A. (2008): Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern. Microbes Infect 10, 103-13.
    • (2008) Microbes Infect , vol.10 , pp. 103-113
    • Sathlera-Velar, R.1    Vitellia-Velar, D.M.2    Massara, R.L.3    de Lana, M.4    Pinto, D.J.C.5    Teixeira-Carvalho, A.6    Eloi-Santos, S.M.7    Martins-Filho, O.A.8
  • 93
    • 77952215586 scopus 로고    scopus 로고
    • Chagas disease: A Latin American health problem becoming a world health problem
    • SCHMUNIS, G. A. and YADON, Z. E. (2009): Chagas disease: A Latin American health problem becoming a world health problem. Acta Trop.
    • (2009) Acta Trop
    • Schmunis, G.A.1    Yadon, Z.E.2
  • 94
    • 3142735123 scopus 로고    scopus 로고
    • The role of nitric oxide in the pathogenesis of Chagas disease
    • SILVA, J. S., MACHADO, F. S. and MARTINS, G. A. (2003): The role of nitric oxide in the pathogenesis of Chagas disease. Front Biosci 8, s314-25.
    • (2003) Front Biosci , vol.8
    • Silva, J.S.1    Machado, F.S.2    Martins, G.A.3
  • 96
    • 84868882513 scopus 로고    scopus 로고
    • Prevention strategies of cardioembolic ischemic stroke in Chagas disease
    • SOUSA, A. S., XAVIER, S. S., FREITAS, G. R. and HASSLOCHERMORENO, A. (2008): Prevention strategies of cardioembolic ischemic stroke in Chagas disease. Arq Bras Cardiol 91, 306-10.
    • (2008) Arq Bras Cardiol , vol.91 , pp. 306-310
    • Sousa, A.S.1    Xavier, S.S.2    Freitas, G.R.3    Hasslochermoreno, A.4
  • 97
    • 67349165445 scopus 로고    scopus 로고
    • Chagas disease alters the relationship between heart rate variability and daily physical activity
    • SOUSA, L., ROCHA, M. O., BRITTO, R. R., LOMBARDI, F. and RIBEIRO, A. L. (2009): Chagas disease alters the relationship between heart rate variability and daily physical activity. Int J Cardiol 135, 257-9.
    • (2009) Int J Cardiol , vol.135 , pp. 257-259
    • Sousa, L.1    Rocha, M.O.2    Britto, R.R.3    Lombardi, F.4    Ribeiro, A.L.5
  • 101
    • 0029070251 scopus 로고
    • Coronary vascular reactivity is abnormal in patients with Chagas heart disease
    • TORRES, F. W., ACQUATELLA, H., CONDADO, J. A., DINSMORE, R. and PALACIOS, I. F. (1995): Coronary vascular reactivity is abnormal in patients with Chagas heart disease. Am Heart J 129, 995-1001.
    • (1995) Am Heart J , vol.129 , pp. 995-1001
    • Torres, F.W.1    Acquatella, H.2    Condado, J.A.3    Dinsmore, R.4    Palacios, I.F.5
  • 102
    • 0242606062 scopus 로고    scopus 로고
    • Role of IFN-alpha/beta and IL-12 in the activation of natural killer cells and interferongamma production during experimental infection with Trypanosoma cruzi
    • UNE, C., ANDERSSON, J. and ORN, A. (2003): Role of IFN-alpha/beta and IL-12 in the activation of natural killer cells and interferongamma production during experimental infection with Trypanosoma cruzi. Clin Exp Immunol 134, 195-201.
    • (2003) Clin Exp Immunol , vol.134 , pp. 195-201
    • Une, C.1    Andersson, J.2    Orn, A.3
  • 103
    • 69049116505 scopus 로고    scopus 로고
    • Ergosterol biosynthesis and drug development for Chagas disease
    • URBINA, J. A. (2009a): Ergosterol biosynthesis and drug development for Chagas disease. Mem Inst Oswaldo Cruz 104 Suppl 1, 311-8.
    • (2009) Mem Inst Oswaldo Cruz , vol.104 , Issue.SUPPL. 1 , pp. 311-318
    • Urbina, J.A.1
  • 104
    • 77952224485 scopus 로고    scopus 로고
    • Specific Chemotherapy of Chagas Disease: Relevance, Current Limitations and New Approaches
    • URBINA, J. A. (2009b): Specific Chemotherapy of Chagas Disease: Relevance, Current Limitations and New Approaches. Acta Trop.
    • (2009) Acta Trop
    • Urbina, J.A.1
  • 106
    • 33646847271 scopus 로고    scopus 로고
    • Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: A nonrandomized trial
    • VIOTTI, R., VIGLIANO, C., LOCOCO, B., BERTOCCHI, G., PETTI, M., ALVAREZ, M. G., POSTAN, M. and ARMENTI, A. (2006): Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 144, 724-34.
    • (2006) Ann Intern Med , vol.144 , pp. 724-734
    • Viotti, R.1    Vigliano, C.2    Lococo, B.3    Bertocchi, G.4    Petti, M.5    Alvarez, M.G.6    Postan, M.7    Armenti, A.8
  • 107
    • 70350307193 scopus 로고    scopus 로고
    • Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas disease
    • WAGHABI, M. C., DE SOUZA, E. M., DE OLIVEIRA, G. M., KERAMIDAS, M., FEIGE, J. J., ARAUJO-JORGE, T. C. and BAILLY, S. (2009): Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas disease. Antimicrob Agents Chemother 53, 4694-701.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 4694-4701
    • Waghabi, M.C.1    de Souza, E.M.2    de Oliveira, G.M.3    Keramidas, M.4    Feige, J.J.5    Araujo-Jorge, T.C.6    Bailly, S.7
  • 110


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.